R. Lepeule
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 17
-
- Antibiotic Use and Resistance 6
- Co-authors
- Étienne RuppéFrançois BarbierJean‐Christophe LucetB. FantinPaul‐Louis WoertherCécile AngebaultCharles BurdetAntoine Andremont
- Journals
- Journal of Antimicrobial Chemotherapy (6 papers)International Journal of Antimicrobial Agents (5 papers)Journal of Clinical Medicine (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)Annals of Intensive Care (2 papers)
- Partner nations
- FranceItalySwitzerland
In The Last Decade
R. Lepeule
62 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 93
- Applied Microbiology and Biotechnology 196
- Molecular Medicine 361
- Clinical Biochemistry 177
- Endocrinology 132
- Critical Care and Intensive Care Medicine 103
Countries citing papers authored by R. Lepeule
This map shows the geographic impact of R. Lepeule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Lepeule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Lepeule more than expected).
Fields of papers citing papers by R. Lepeule
This network shows the impact of papers produced by R. Lepeule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Lepeule. The network helps show where R. Lepeule may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Lepeule, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 14 | |
| 6 | 2020 | 9 | |
| 7 | 2019 | 3 | |
| 8 | 2019 | 6 | |
| 9 | 2018 | 26 | |
| 10 | 2018 | 11 | |
| 11 | 2018 | 47 | |
| 12 | 2018 | 42 | |
| 13 | 2017 | 66 | |
| 14 | 2017 | 47 | |
| 15 | 2016 | 6 | |
| 16 | 2015 | 7 | |
| 17 | 2015 | 1 | |
| 18 | 2014 | 12 | |
| 19 | 2013 | 16 | |
| 20 | 2013 | 16 |
About R. Lepeule
R. Lepeule is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry, Microbiology and Epidemiology, having authored 69 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (17 papers), Infective Endocarditis Diagnosis and Management (16 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Streptococcal Infections and Treatments (13 papers), Bacterial Identification and Susceptibility Testing (13 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Urinary Tract Infections Management (11 papers) and Antibiotic Use and Resistance (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (196 citations), Molecular Medicine (361 citations), Clinical Biochemistry (177 citations), Endocrinology (132 citations) and Critical Care and Intensive Care Medicine (103 citations). R. Lepeule has collaborated with scholars based in France, Italy and Switzerland. Frequent co-authors include Étienne Ruppé, François Barbier, Jean‐Christophe Lucet, B. Fantin, Paul‐Louis Woerther, Cécile Angebault, Charles Burdet, Antoine Andremont, Patrick Plésiat and Laurence Armand-Lefèvre. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, Journal of Clinical Medicine, Antimicrobial Agents and Chemotherapy and Annals of Intensive Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.